Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area

Genes Chromosomes and Cancer

Volumn 54, Issue 1, 2015, Pages 51-62

  Betti, Marta ^a   Casalone, Elisabetta ^a   Ferrante, Daniela ^a   Romanelli, Antonio ^b   Grosso, Federica ^c   Guarrera, Simonetta ^d,e   Righi, Luisella ^e   Vatrano, Simona ^e   Pelosi, Giuseppe ^f,g   Libener, Roberta ^c   Mirabelli, Dario ^h   Boldorini, Renzo ^a   Casadio, Caterina ^a,i   Papotti, Mauro ^e   Matullo, Giuseppe ^d,e,h   Magnani, Corrado ^a,h   Dianzani, Irma ^a,h  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b Department of Public Health   (Italy)

^c SS Antonio e Biagio General Hospital   (Italy)

^d Human Genetics Foundation   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h UNIVERSITY OF TURIN   (Italy)

ⁱ Thoracic Surgery Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; BRCA1 ASSOCIATED PROTEIN 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; BAP1 PROTEIN, HUMAN; POLLUTANT; UBIQUITIN THIOLESTERASE;

ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; DNA EXTRACTION; EXPOSURE; FAMILIAL CANCER; FEMALE; GENETIC PREDISPOSITION; GERMLINE MUTATION; HIGH RISK POPULATION; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; LEUKEMIA; LIVER CELL CARCINOMA; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT MESOTHELIOMA; MELANOMA; METASTASIS; OCCUPATION; PERITONEUM MESOTHELIOMA; PLEURA MESOTHELIOMA; PLEURA THICKENING; PRIORITY JOURNAL; PROSTATE CANCER; SEQUENCE ANALYSIS; TUMOR SUPPRESSOR GENE; ADVERSE EFFECTS; CASE REPORT; CHEMICALLY INDUCED; ENVIRONMENTAL EXPOSURE; GENETICS; LUNG TUMOR; MESOTHELIOMA; MIDDLE AGED; POLLUTANT; RISK FACTOR; TOXICITY;

ADULT; AGED; ASBESTOS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; FEMALE; GERM-LINE MUTATION; HUMANS; LUNG NEOPLASMS; MALE; MESOTHELIOMA; MIDDLE AGED; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84922337420     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22218     Document Type: Article

References (39)

1. Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, Hovland P, Davidorf FH. 2011. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 48:856-859.
2. Aoude LG, Vajdic CM, Kricker A, Armstrong B, Hayward NK. 2013. Prevalence of germline BAP1 mutation in a population-based sample of uveal melanoma cases. Pigment Cell Melanoma Res 26:278-279.
3. Aoude LG, Wadt K, Bojesen A, Crüger D, Borg A, Trent JM, Brown KM, Gerdes AM, Jönsson G, Hayward NK. 2013. A BAP1 mutation in a Danish family predisposes to uveal melanoma and other cancers. PLoS One 8:e72144.
4. Ascoli V, Cavone D, Merler E, Barbieri PG, Romeo L, Nardi F, Musti M. 2007. Mesothelioma in blood related subjects: Report of 11 clusters among 1954 Italy cases and review of the literature. Am J Ind Med 50:357-369.
5. Ascoli V, Romeo E, Carnovale Scalzo C, Cozzi I, Ancona L, Caraviani F, Balestri A, Gasperini L, Forastiere F. 2014. Familial malignant mesothelioma: A population-based study in Central Italy (1980-2012). Cancer Epidemiol 38:273-278.
6. Betti M, Ferrante D, Padoan M, Guarrera S, Giordano M, Aspesi A, Mirabelli D, Casadio C, Ardissone F, Ruffini E, Betta PG, Libener R, Guaschino R, Matullo G, Piccolini E, Magnani C, Dianzani I. 2011. XRCC1 and ERCC1 variants modify malignant mesothelioma risk: A case-control study. Mutat Res 708:11-20.
7. Breslow NE, Day NE. 1980. Statistical methods in cancer research. Volume I-The analysis of case-control studies. IARC Sci Publ 32:5-338.
8. Cadby G, Mukherjee S, Musk AW, Reid A, Garlepp M, Dick I, Robinson C, Hui J, Fiorito G, Guarrera S, Beilby J, Melton PE, Moses EK, Ugolini D, Mirabelli D, Bonassi S, Magnani C, Dianzani I, Matullo G, Robinson B, Creaney J, Palmer LJ. 2013. A genome-wide association study for malignant mesothelioma risk. Lung Cancer 82:1-8.
9. Cheung M, Talarchek J, Schindeler K, Saraiva E, Penney LS, Ludman M, Testa JR. 2013. Further evidence for germline BAP1 mutations predisposing to melanoma and malignant mesothelioma. Cancer Genet 206:206-210.
10. Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS, Kirkpatrick DS, Pham VC, Lill JR, Bakalarski CE, Wu J, Phu L, Katavolos P, LaFave LM, Abdel-Wahab O, Modrusan Z, Seshagiri S, Dong K, Lin Z, Balazs M, Suriben R, Newton K, Hymowitz S, Garcia-Manero G, Martin F, Levine RL, Dixit VM. 2012. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 337:1541-1546.
11. Dogan AU, Baris YI, Dogan M, Emri S, Steele I, Elmishad AG, Carbone M. 2006. Genetic predisposition to fiber carcinogenesis causes a mesothelioma epidemic in Turkey. Cancer Res 66:5063-5068.
12. Farley MN, Schmidt LS, Mester JL, Peña-Llopis S, Pavia-Jimenez A, Christie A, Vocke CD, Ricketts CJ, Peterson J, Middelton L, Kinch L, Grishin N, Merino MJ, Metwalli AR, Xing C, Xie XJ, Dahia PL, Eng C, Linehan WM, Brugarolas J. 2013. A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol Cancer Res 11:1061-1071.
13. Fazzo L, De Santis M, Minelli G, Bruno C, Zona A, Marinaccio A, Conti S, Comba P. 2012. Pleural mesothelioma mortality and asbestos exposure mapping in Italy. Am J Ind Med 55:11-24.
14. Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, Council ML, Matatall KA, Helms C, Bowcock AM. 2010. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330:1410-1413.
15. Hodgson JT, Darnton A. 2000. The Quantitative Risks of Mesothelioma and Lung Cancer in Relation to Asbestos Exposure. Ann Occup Hyg 44:565-601.
16. Hoiom V, Edsgard D, Helgadottir H, Eriksson H, All-Ericsson C, Tuominen R, Ivanova I, Lundeberg J, Emanuelsson O, Hansson J. 2013. Hereditary uveal melanoma: A report of a germline mutation in BAP1. Genes Chromosomes Cancer 52:378-384.
17. Maerker DA, Zeschnigk M, Nelles J, Lohmann DR, Worm K, Bosserhoff AK, Krupar R, Jägle H. 2014. BAP1 germline mutation in two first grade family members with uveal melanoma. Br J Ophthalmol 98:224-227.
18. Magnani C, Agudo A, González CA, Andrion A, Calleja A, Chellini E, Dalmasso P, Escolar A, Hernandez S, Ivaldi C, Mirabelli D, Ramirez J, Turuguet D, Usel M, Terracini B. 2000. Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos. Br J Cancer 83:104-111.
19. Magnani C, Ferrante D, Barone-Adesi F, Bertolotti M, Todesco A, Mirabelli D, Terracini B. 2008. Cancer risk after cessation of asbestos exposure: A cohort study of Italian asbestos cement workers. Occup Environ Med 65:164-170.
20. Marinaccio A, Binazzi A, Marzio DD, Scarselli A, Verardo M, Mirabelli D, Gennaro V, Mensi C, Riboldi L, Merler E, Zotti RD, Romanelli A, Chellini E, Silvestri S, Pascucci C, Romeo E, Menegozzo S, Musti M, Cavone D, Cauzillo G, Tumino R, Nicita C, Melis M, Iavicoli S; ReNaM Working Group. 2012. Pleural malignant mesothelioma epidemic: Incidence, modalities of asbestos exposure and occupations involved from the Italian National Register. Int J Cancer 130:2146-2154.
21. Matullo G, Guarrera S, Betti M, Fiorito G, Ferrante D, Voglino F, Cadby G, Di Gaetano C, Rosa F, Russo A, Hirvonen A, Casalone E, Tunesi S, Padoan M, Giordano M, Aspesi A, Casadio C, Ardissone F, Ruffini E, Betta PG, Libener R, Guaschino R, Piccolini E, Neri M, Musk AWB, de Klerk NH, Hui J, Beilby J, James AL, Creaney J, Robinson BW, Mukherjee S, Palmer LJ, Mirabelli D, Ugolini D, Bonassi S, Magnani C, Dianzani I. 2013. Genetic variants associated to an increased risk of malignant pleural mesothelioma: A genome-wide association study. Plos One 8:e61253.
22. Maule MM, Magnani C, Dalmasso C, Mirabelli D, Merletti F, Biggeri A. 2007. Modeling mesothelioma risk associated with environmental asbestos exposure. Env Hlt Persp 115:1066-1071.
23. Murali R, Wiesner T, Scolyer RA. 2013. Tumours associated with BAP1 mutations. Pathology 45:116-126.
24. Neri M, Ugolini D, Dianzani I, Gemignani F, Landi S, Cesario A, Magnani C, Mutti L, Puntoni R, Bonassi S. 2008. Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases. Mutat Res 659:126-136.
25. Njauw CN, Kim I, Piris A, Gabree M, Taylor M, Lane AM, DeAngelis MM, Gragoudas E, Duncan LM, Tsao H. 2012. Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One 7:e35295.
26. Oddone E, Ferrante D, Cena T, Tùnesi S, Amendola P, Magnani C. 2014. Asbestos cement factory in Broni (Pavia, Italy): A mortality study. Med Lav 105:15-29.
27. Pilarski R, Cebulla CM, Massengill JB, Rai K, Rich T, Strong L, McGillivray B, Asrat MJ, Davidorf FH, Abdel-Rahman MH. 2014. Expanding the clinical phenotype of hereditary BAP1 cancer predisposition syndrome, reporting three new cases. Genes Chromosomes Cancer 53:177-182.
28. Pinto C, Novello S, Torri V, Ardizzoni A, Betta PG, Bertazzi PA, Casalini GA, Fava C, Fubini B, Magnani C, Mirabelli D, Papotti M, Ricardi U, Rocco G, Pastorino U, Tassi G, Trodella L, Zompatori M, Scagliotti G. 2013. Second Italian Consensus Conference on Malignant Pleural Mesothelioma: State of the art and recommendations. Cancer Treat Rev 39:328-339.
29. Popova T, Hebert L, Jacquemin V, Gad S, Caux-Moncoutier V, Dubois-d'Enghien C, Richaudeau B, Renaudin X, Sellers J, Nicolas A, Sastre-Garau X, Desjardins L, Gyapay G, Raynal V, Sinilnikova OM, Andrieu N, Manié E, de Pauw A, Gesta P, Bonadona V, Maugard CM, Penet C, Avril MF, Barillot E, Cabaret O, Delattre O, Richard S, Caron O, Benfodda M, Hu HH, Soufir N, Bressac-de Paillerets B, Stoppa-Lyonnet D, Stern MH. 2013. Germline BAP1 Mutations Predispose to Renal Cell Carcinomas. Am J Hum Genet 92:974-980.
30. Ribeiro C, Campelos S, Moura CS, Machado JC, Justino A, Parente B. 2013. Well-differentiated papillary mesothelioma: Clustering in a Portuguese family with a germline BAP1 mutation. Ann Oncol 24:2147-2150.
31. Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, Cox NJ, Dogan AU, Pass HI, Trusa S, Hesdorffer M, Nasu M, Powers A, Rivera Z, Comertpay S, Tanji M, Gaudino G, Yang H, Carbone M. 2011. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 43:1022-1025.
32. Travis WD, Brambilla E, Mueller-Hermelink HK, Harris CC. 2004. World Health Organization Classification of tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press, pp. 125-136.
33. Wadt K, Choi J, Chung JY, Kiilgaard J, Heegaard S, Drzewiecki KT, Trent JM, Hewitt SM, Hayward NK, Gerdes AM, Brown KM. 2012. A cryptic BAP1 splice mutation in a family with uveal and cutaneous melanoma, and paraganglioma. Pigment Cell Melanoma Res 25:815-818.
34. White AE, Harper JW. 2012. Cancer. Emerging anatomy of the BAP1 tumor suppressor system. Science 337:1463-1464.
35. Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, Windpassinger C, Wackernagel W, Loy S, Wolf I, Viale A, Lash AE, Pirun M, Socci ND, Rütten A, Palmedo G, Abramson D, Offit K, Ott A, Becker JC, Cerroni L, Kutzner H, Bastian BC, Speicher MR. 2011. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 43:1018-1021.
36. Wiesner T, Fried I, Ulz P, Stacher E, Popper H, Murali R, Kutzner H, Lax S, Smolle-Juttner F, Geigl JB, Speicher MR. 2012. Toward an improved definition of the tumor spectrum associated with BAP1 germline mutations. J Clin Oncol 30:e337-e340.
37. Wiesner T, Murali R, Fried I, Cerroni L, Busam K, Kutzner H, Bastian BC. 2012. A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression. Am J Surg Pathol 36:818-830.
38. Yoshikawa Y, Sato A, Tsujimura T, Emi M, Morinaga T, Fukuoka K, Yamada S, Murakami A, Kondo N, Matsumoto S, Okumura Y, Tanaka F, Hasegawa S, Nakano T, Hashimoto-Tamaoki T. 2012. Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma. Cancer Sci 103:868-874.
39. Zauderer MG, Bott M, McMillan R, Sima CS, Rusch V, Krug LM, Ladanyi M. 2013. Clinical Characteristics of Patients with Malignant Pleural Mesothelioma Harboring Somatic BAP1 Mutations. J Thorac Oncol 8:1430-1433.